Methylphenidate in Early Poststroke Recovery

Completed

Phase 2 Results

Summary of Purpose

To determine the efficacy and safety of methylphenidate in acute stroke rehabilitation.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 October 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • CibaGeneva Pharmaceuticals and Ciba-Geigy Corporation

Trial Design

Prospective, randomized, double-blind, placebo-controlled study involving 21 patients at a single center.

Contacts

Not available